Accretion Pha.

Unicorn Fund acquired 3,07,200 shares, representing a 2.76% stake in Accretion Pharmaceuticals, for ₹4.77 crore at ₹155.50 per share.

A pharmaceutical manufacturer incorporated in 2012, Accretion Pharmaceuticals produces tablets, capsules, and other healthcare products for domestic and international markets. The company operates across multiple therapeutic segments, focusing on formulation development, quality manufacturing, and distribution. Its distinctive strength lies in vertically integrated operations combining research capabilities with modern production facilities and a wide distribution network across India and select overseas regions.

Ahmedabad-based with positions across smallcap and midcap listed equities.